Sign in
4

Changes in Ownership

Dare Bioscience, Inc. Filed Acc 0001209191-16-090356

Options or other derivatives

  • Chief Executive Officer acquired 137,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
GUIFFRE CHRISTOPHERD T Chief Executive Officer 2016-01-05 Grant or award · Incentive Stock Option (right to buy) +137,000 137,000 D: show line 1 in the form
Loading xslF345X03/doc4.xml…